In this interview, Tony Street addresses questions about the role of technology in a fully integrated clinical trial supply chain, from forecasting and proactive planning, to distribution to sites and patients, to final reconciliation. Tony will also talk about the current s … Read More »
Mark Archer, Global Head of Business Development of inVentiv Health
Old commercialization models are being redefined by new market realities, transforming the way biopharmaceutical companies need to do business. inVentiv Health has redefined Clinical and Commercial services to give biopharmaceutical companies a better way to create value. In … Read More »
This podcast covers research findings from the digital health debate, product commercialization issues, the future of pharma reps, the move to mobile by physicians, and more. Please download the related white paper on this topic.
In this episode, Mr. Akkerman talks about good manufacturing practice (GMP), its use in early drug development, issues related to facilities preparation, considerations regarding radiolabeled compounds and the effects of onsite manufacturing on your budget. Download a relate … Read More »
Vice President, Global Solutions
Industry Vertical Leader, Life Sciences
Kelly Services, Inc.
In this episode, Kevin D. Duffy discusses sourcing talent in the life science industry, strategic partnering for acquiring talent, the concept of talent supply chain management, and a glimpse into the future.
Head of Global Brand & Customer Experience
In this episode, Mark Sales discusses pharma brand marketing, product marketing, B2B vs. B2C, and how pharma marketers can make improvements in traditional areas of weakness. You can also download a related white paper on pharma brand marketing.
SVP, Behavioral Strategy
Adheris Health, Behavioral Insights Group of inVentiv Health
In this episode, you’ll hear a conversation with Dr. Kathleen Starr, a psychologist and leader of a team of behavioral scientists at inVentiv Health. Kathleen is interviewed by Sydney Rubin, a senior communications consultant with inVentiv Health. You are also encouraged to … Read More »
In this episode, Mr. Fronstin illustrates the size and scope of the pain market, addresses current unmet needs, outlines promising new Mechanisms of Action, and covers the implications for the pharma industry.
In this episode, Mr. Patel talks about data security, US legislation, including the Affordable Care Act, safeguards that can be implemented, and other challenges regarding data security. Download the related whitepaper entitled 'Global Digital Security: The Human Elemen … Read More »
In this episode, Mr. McCormick talks about outsourced contact centers serving the healthcare industry and focuses on TrialCard's customer experience center. Download the related whitepaper entitled 'What Would Alexander Graham Bell Think Of Today's Contact Cen … Read More »
In this episode, Mr. Domann discusses a retail strategy for minimizing prescription abandonment for brands at many stages in the product lifecycle. We cover how pharmacies and pharmacists play integral roles in the strategy.
In this episode, Patricia Ensor discusses the characteristics and behaviors of the uninsured, how they relate to the Affordable Care Act (ACA), and what it means for Pharma.
In this episode, Mr. Yoder talks about how optimizing is not the same as cost reduction. He also covers the challenges, benefits, and what the future of clinical supply optimization looks like.